Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05NEK
|
|||
| Drug Name |
N-acetylcysteine
|
|||
| Synonyms |
N-Acetyl-L-cysteine; acetylcysteine; 616-91-1; N-Acetylcysteine; mercapturic acid; Acetadote; L-Acetylcysteine; Broncholysin; Fluimucil; Mucomyst; N-Acetyl-cysteine; Parvolex; Fluprowit; Acetein; Airbron; Fabrol; Flumucetin; Mucosolvin; Fluimucetin; Mucosil; Brunac; Fluimicil Infantil; Acetylcysteinum; Acetilcisteina; Respaire; Mucofilin; Lysomucil; Exomuc; Inspir; Ac-Cys-OH; Mucolyticum Lappe; Mucolytikum Lappe; N-Acetyl cysteine; Mucolyticum; LNAC; N-Acetyl-3-mercaptoalanine; N-Acetyl-L-(+)-cysteine; Neo-fluimucil; NAC-TB; Mucolyticum-Lappe; (R; Acetylcysteine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cystic fibrosis [ICD-11: CA25; ICD-10: E84, E84.9; ICD-9: 277] | Approved | [1] | |
| Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [2] | ||
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H9NO3S
|
|||
| Canonical SMILES |
CC(=O)NC(CS)C(=O)O
|
|||
| InChI |
1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1
|
|||
| InChIKey |
PWKSKIMOESPYIA-BYPYZUCNSA-N
|
|||
| CAS Number |
CAS 616-91-1
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:28939
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 074037. | |||
| REF 2 | ClinicalTrials.gov (NCT04279197) Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.